Coadministration of telaprevir and transcatheter arterial chemoembolization in hepatitis c virus-associated hepatocellular carcinoma

World Journal of Hepatology

Volumn 5, Issue 6, 2013, Pages 332-335

  Torres, Harrys A ^a   Mahale, Parag ^a   Miller, Ethan D ^a   Oo, Thein H ^a   Frenette, Catherine ^b   Kaseb, Ahmed O ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Cancer; Hepatitis C virus; Hepatocellular carcinoma; Interactions; Telaprevir; Transcatheter arterial chemoembolization

Indexed keywords

EID: 84880654689     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v5.i6.332     Document Type: Article

References (20)

1. Poordad F, McCone J, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy KR, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Bronowicki JP. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1195-1206 [PMID: 21449783 DOI: 10.1056/NEJMoa1010494]
2. Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, Burroughs M, Brass CA, Albrecht JK, Esteban R. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1207-1217 [PMID: 21449784 DOI: 10.1056/NEJMoa1009482]
3. Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem S. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011; 364: 2405-2416 [PMID: 21696307 DOI: 10.1056/NEJMoa1012912]
4. Ghany MG, Nelson DR, Strader DB, Thomas DL, SeeffLB. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54: 1433-1444 [PMID: 21898493 DOI: 10.1002/hep.24641]
5. Gigliotti AR, Fioredda F, Giacchino R. Hepatitis B and C infection in children undergoing chemotherapy or bone marrow transplantation. J Pediatr Hematol Oncol 2003; 25: 184-192 [PMID: 12621235 DOI: 10.1097/00043426-200303000-00002]
6. Firpi RJ, Nelson DR. Management of viral hepatitis in hematologic malignancies. Blood Rev 2008; 22: 117-126 [PMID: 18343002 DOI: 10.1016/j.blre.2008.02.001]
7. Zuckerman E, Zuckerman T, Douer D, Qian D, Levine AM. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer 1998; 83: 1224-1230 [PMID: 9740089 DOI: 10.1002/(SI CI)1097-0142(19980915)83:]
8. Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M, Torres HA. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol 2012; 57: 1177-1185 [PMID: 22871500 DOI: 10.1016/j.jhep.2012.07.031]
9. Torres HA, Davila M. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol 2012; 9: 156-166 [PMID: 22271089 DOI: 10.1038/nrclinonc. 2012.1]
10. Papaevangelou V, Varsami M, Papadakis V, Zellos A, Parcharidou A, Papargyri S, Karentzou O, Manolaki N, Roma E, Polychronopoulou S. Hepatitis C treatment concomitant to chemotherapy as "salvage" therapy in children with hematologic malignancies. Pediatr Infect Dis J 2010; 29: 277-280 [PMID: 19949358 DOI: 10.1097/INF.0b013e3181c2115a]
11. Farmer RW, Kralj I, Valdata A, Urbano J, Enguix DP, García Mónaco R, Scoggins CR, McMasters KM, Rustein L, Martin RC. Hepatic arterial therapy as a bridge to ablation or transplant in the treatment of hepatocellular carcinoma. Am Surg 2011; 77: 868-873 [PMID: 21944349]
12. De Luna W, Sze DY, Ahmed A, Ha BY, Ayoub W, Keeffe EB, Cooper A, Esquivel C, Nguyen MH. Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation. Am J Transplant 2009; 9: 1158-1168 [PMID: 19344435 DOI: 10.1111/j.1600-6143.2009.02576.x]
13. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699 [PMID: 8594428 DOI: 10.1056/NEJM199603143341104]
14. Wertheim JA, Petrowsky H, Saab S, Kupiec-Weglinski JW, Busuttil RW. Major challenges limiting liver transplantation in the United States. Am J Transplant 2011; 11: 1773-1784 [PMID: 21672146 DOI: 10.1111/j.1600-6143.2011.03587.x]
15. Terrault NA. Hepatitis C therapy before and after liver transplantation. Liver Transpl 2008; 14 Suppl 2: S58-S66 [PMID: 18825697 DOI: 10.1002/lt.21624]
16. Everson GT, Trotter J, Forman L, Kugelmas M, Halprin A, Fey B, Ray C. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 2005; 42: 255-262 [PMID: 16025497 DOI: 10.1002/hep.20793]
17. Garg V, van Heeswijk R, Lee JE, Alves K, Nadkarni P, Luo X. Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus. Hepatology 2011; 54: 20-27 [PMID: 21618566 DOI: 10.1002/hep.24443]
18. Gupta S, Wright KC, Ensor J, Van Pelt CS, Dixon KA, Kundra V. Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model. Cardiovasc Intervent Radiol 2011; 34: 1021-1030 [PMID: 21479746 DOI: 10.1007/s00270-011-0154-6]
19. Varela M, Real MI, Burrel M, Forner A, Sala M, Brunet M, Ayuso C, Castells L, Montañá X, Llovet JM, Bruix J. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 2007; 46: 474-481 [PMID: 17239480 DOI: 10.1016/j.jhep.2006.10.020]
20. European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943 [PMID: 22424438]